Source:http://linkedlifedata.com/resource/pubmed/id/20542321
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
1
|
| pubmed:dateCreated |
2010-7-12
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jul
|
| pubmed:issn |
1097-6825
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:volume |
126
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
183-4; author reply 184
|
| pubmed:meshHeading |
pubmed-meshheading:20542321-Cyclosporine,
pubmed-meshheading:20542321-Dermatitis, Atopic,
pubmed-meshheading:20542321-Dose-Response Relationship, Drug,
pubmed-meshheading:20542321-Humans,
pubmed-meshheading:20542321-Immunosuppressive Agents,
pubmed-meshheading:20542321-Interleukin-2,
pubmed-meshheading:20542321-T-Lymphocytes, Regulatory
|
| pubmed:year |
2010
|
| pubmed:articleTitle |
Low-dose, but not high-dose, cyclosporin A promotes regulatory T-cell induction, expansion, or both.
|
| pubmed:publicationType |
Letter,
Comment
|